
Join to View Full Profile
405 Momany DrSaint Joseph, MI 49085
Phone+1 269-928-1947
Fax+1 269-982-1950
Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Loyola Medicine MacNeal HospitalResidency, Family Medicine, 1999 - 2002
- Wayne State University School of MedicineClass of 1999
Certifications & Licensure
- FL State Medical License 2023 - 2027
- MI State Medical License 2002 - 2027
- CA State Medical License 2024 - 2026
- TX State Medical License 2024 - 2026
- AZ State Medical License 2024 - 2024
- IL State Medical License 1999 - 2002
- American Board of Family Medicine Family Medicine
Clinical Trials
- VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors Start of enrollment: 2023 Apr 18
Publications & Presentations
PubMed
- 52 citationsCell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.Susan Marie Westaway, Alex Preston, Michael David Barker, Fiona Brown, Jack A. Brown
Journal of Medicinal Chemistry. 2016-01-15 - 3 citationsElectron attachment to sulfur oxyhalides: SOF2, SOCl2, SO2F2, SO2Cl2, and SO2FCl attachment rate coefficients, 300–900 KThomas M. Miller, Jeffrey F. Friedman, Connor M. Caples, Nicholas S. Shuman, Jane M. Van Doren
The Journal of Chemical Physics. 2010-06-07 - Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs.Savvas Kleanthous, Alan D Borthwick, David Brown, Cynthia L Burns-Kurtis, Matthew Campbell
Bioorganic & Medicinal Chemistry Letters. 2010-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: